Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Harold Bays, Angela Fitch, Sandra Christensen, et al.
Obesity Pillars (2022) Vol. 2, pp. 100018-100018
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Wissam Ghusn, Alan De la Rosa, Daniel Sacoto, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231982-e2231982
Open Access | Times Cited: 134
Ten things to know about ten cardiovascular disease risk factors – 2022
Harold Bays, Anandita Agarwala, Charles German, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100342-100342
Open Access | Times Cited: 79
Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation
Sarah Nutter, Laura Ann Eggerichs, Taniya S. Nagpal, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 77
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e320-e350
Open Access | Times Cited: 27
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki, et al.
Obesity Pillars (2024) Vol. 10, pp. 100108-100108
Open Access | Times Cited: 19
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Marie Ng, Emmanuela Gakidou, Justin Lo, et al.
The Lancet (2025) Vol. 405, Iss. 10481, pp. 813-838
Open Access | Times Cited: 7
Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
Harold Bays, Shagun Bindlish, Tiffany Lowe Clayton
Obesity Pillars (2023) Vol. 5, pp. 100056-100056
Open Access | Times Cited: 32
Weight loss efficiency and safety of tirzepatide: A Systematic review
Fei Lin, Bin Yu, Baodong Ling, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285197-e0285197
Open Access | Times Cited: 31
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Ethan Lazarus, Harold Bays
Obesity Pillars (2022) Vol. 3, pp. 100026-100026
Open Access | Times Cited: 35
Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023
Tiffany Lowe Clayton, Angela Fitch, Harold Bays
Obesity Pillars (2023) Vol. 8, pp. 100083-100083
Open Access | Times Cited: 18
Highly expandable edible hydrogels for the prevention and treatment of obesity through dietary intervention
Huiyuan Yang, Haixia Yang, Chenhui Zhu, et al.
Food Hydrocolloids (2023) Vol. 144, pp. 108946-108946
Closed Access | Times Cited: 17
Anti-Obesity Therapeutic Targets Studied In Silico and In Vivo: A Systematic Review
Wendjilla Fortunato de Medeiros, Ana Francisca Teixeira Gomes, Ana Aguiar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4699-4699
Open Access | Times Cited: 6
Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Harold Bays, Angela Golden, Justin Tondt
Obesity Pillars (2022) Vol. 3, pp. 100034-100034
Open Access | Times Cited: 26
Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023
Shagun Bindlish, Jennifer Ng, Wissam Ghusn, et al.
Obesity Pillars (2023) Vol. 8, pp. 100092-100092
Open Access | Times Cited: 13
Pharmacological treatment of obesity in adults in Norway 2004–2022
Paz Lopez‐Doriga Ruiz, Øystein Karlstad, Kjersti Nøkleby, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2102-2110
Open Access | Times Cited: 5
A review of the evidence on cardiovascular outcomes from obesity treatment
Roshaida Abdul Wahab, Carel W. le Roux
Obesity Pillars (2023) Vol. 7, pp. 100071-100071
Open Access | Times Cited: 12
Comprehensive care for patients with obesity: An Obesity Medicine Association Position Statement
Angela Fitch, Lydia Alexander, C. Brown, et al.
Obesity Pillars (2023) Vol. 7, pp. 100070-100070
Open Access | Times Cited: 11
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs
Sandra M. Christensen, Katie N. Robinson, Sara Thomas, et al.
Obesity Pillars (2024) Vol. 11, pp. 100121-100121
Open Access | Times Cited: 4
Role of pancreatic lipase inhibition in obesity treatment: mechanisms and challenges towards current insights and future directions
Vetriselvan Subramaniyan, Yusoff Umul Hanim
International Journal of Obesity (2025)
Open Access
Obesity Management in Primary Care: A Joint Clinical Perspective and Expert Review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025
N. J. Pennings, Catherine Varney, Stephanie L. Hines, et al.
Obesity Pillars (2025), pp. 100172-100172
Open Access
Artificial intelligence in anti-obesity drug discovery: unlocking next-generation therapeutics
Amit Gangwal, Antonio Lavecchia
Drug Discovery Today (2025), pp. 104333-104333
Open Access
Hypocaloric low-carbohydrate versus low-fat diets on flow-mediated dilation, blood pressure, cardiovascular biomarkers, and body composition in individuals with overweight or obesity: a systematic review and meta-analysis of randomized clinical trials
Fatemeh Kazeminasab, Maryam Baharlooie, Reza Bagheri, et al.
European Journal of Clinical Nutrition (2025)
Closed Access
Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022
Suzanne Cuda, Marisa Censani, Roohi Y. Kharofa, et al.
Obesity Pillars (2022) Vol. 4, pp. 100048-100048
Open Access | Times Cited: 16
Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review
Harold Bays
Obesity Pillars (2023) Vol. 7, pp. 100076-100076
Open Access | Times Cited: 10
Obesity management for cardiovascular disease prevention
Rama Hritani, Mahmoud Al Rifai, Anurag Mehta, et al.
Obesity Pillars (2023) Vol. 7, pp. 100069-100069
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top